Cyproteronacetaat (Dutch Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cyproteronacetaat" in Dutch language version.

refsWebsite

Global rank Dutch rank

11nih.gov

4^th place

12^th place

11doi.org

2^nd place

8^th place

7archive.today

14^th place

26^th place

4books.google.com

3^rd place

43^rd place

2nos.nl

567^th place

2^nd place

1web.archive.org

1^st place

1ucsf.edu

5,479^th place

low place

archive.today

Diane. Consumentenbond Medicijnwijzer. Gearchiveerd op 22 april 2013.
Diane 35. Consumentenbond Medicijnwijzer. Gearchiveerd op 22 april 2013.
Advies CBG: Diane-35 blijft beschikbaar, maar wordt afgeraden voor nieuwe patiënten. College ter Beoordeling van Geneesmiddelen (8 maart 2013). Gearchiveerd op 25 juni 2013.
Update over Diane-35. College ter Beoordeling van Geneesmiddelen (4 februari 2013). Gearchiveerd op 25 juni 2013.
PRAC-aanbeveling: Diane-35 en generieken beschikbaar houden voor specifieke patiëntengroepen. College ter Beoordeling van Geneesmiddelen (17 mei 2013). Gearchiveerd op 25 juni 2013.
PRAC-aanbeveling Diane-35 en generieke varianten wordt onderschreven door CMDh. College ter Beoordeling van Geneesmiddelen (31 mei 2013). Gearchiveerd op 25 juni 2013.
Nieuwe contra-indicatie, aangepaste indicatie en aanscherping waarschuwingen Diane-35 en generieke varianten. College ter Beoordeling van Geneesmiddelen (24 juni 2013). Gearchiveerd op 25 juni 2013.

books.google.com

Transsexual and Other Disorders of Gender Identity: A Practical Guide to Management. CRC Press (29 september 2017), 216–217, 221. ISBN 978-1-315-34513-0.
Principles of Transgender Medicine and Surgery. Routledge (20 May 2016), 169, 171, 216. ISBN 978-1-317-51460-2.
Transgender Care: Recommended Guidelines, Practical Information, and Personal Accounts. Temple University Press (March 2001), 66–. ISBN 978-1-56639-852-7.
Hair Transplantation, Third Edition. Taylor & Francis (1 February 1995), "Androgenetic alopecia and its treatment. A historical overview", 1–33. ISBN 978-0-8247-9363-0.

doi.org

(January 2008). Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. The Journal of Clinical Endocrinology and Metabolism 93 (1): 19–25. PMID 17986639. DOI: 10.1210/jc.2007-1809.
(November 2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism 102 (11): 3869–3903. PMID 28945902. DOI: 10.1210/jc.2017-01658.
(April 2018). Hormonal Treatment in Young People With Gender Dysphoria: A Systematic Review. Pediatrics 141 (4): e20173742. PMID 29514975. DOI: 10.1542/peds.2017-3742.
(September 2021). Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study. J Clin Endocrinol Metab 106 (10): e3936–e3945. PMID 34125226. PMC 8571811. DOI: 10.1210/clinem/dgab427.
(July 2021). Low-Dose Cyproterone Acetate Treatment for Transgender Women. J Sex Med 18 (7): 1292–1298. PMID 34176757. DOI: 10.1016/j.jsxm.2021.04.008.
(19 August 2022). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health 23 (Suppl 1): S1–S259. PMID 36238954. PMC 9553112. DOI: 10.1080/26895269.2022.2100644.
(September 2018). Transgender medicine - puberty suppression. Reviews in Endocrine & Metabolic Disorders 19 (3): 221–225. PMID 30112593. DOI: 10.1007/s11154-018-9457-0.
(December 2014). Approach to the patient: transgender youth: endocrine considerations. The Journal of Clinical Endocrinology and Metabolism 99 (12): 4379–89. PMID 25140398. DOI: 10.1210/jc.2014-1919.
(April 2018). Hormonal Treatment in Young People With Gender Dysphoria: A Systematic Review. Pediatrics 141 (4): e20173742. PMID 29514975. DOI: 10.1542/peds.2017-3742.
(October 2017). Puberty suppression in transgender children and adolescents. The Lancet. Diabetes & Endocrinology 5 (10): 816–826. PMID 28546095. DOI: 10.1016/S2213-8587(17)30099-2.
(May 2017). Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents. The Journal of Sexual Medicine 14 (5): 747–757. PMID 28499525. DOI: 10.1016/j.jsxm.2017.03.251.

nih.gov

ncbi.nlm.nih.gov

(January 2008). Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. The Journal of Clinical Endocrinology and Metabolism 93 (1): 19–25. PMID 17986639. DOI: 10.1210/jc.2007-1809.
(November 2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism 102 (11): 3869–3903. PMID 28945902. DOI: 10.1210/jc.2017-01658.
(April 2018). Hormonal Treatment in Young People With Gender Dysphoria: A Systematic Review. Pediatrics 141 (4): e20173742. PMID 29514975. DOI: 10.1542/peds.2017-3742.
(September 2021). Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study. J Clin Endocrinol Metab 106 (10): e3936–e3945. PMID 34125226. PMC 8571811. DOI: 10.1210/clinem/dgab427.
(July 2021). Low-Dose Cyproterone Acetate Treatment for Transgender Women. J Sex Med 18 (7): 1292–1298. PMID 34176757. DOI: 10.1016/j.jsxm.2021.04.008.
(19 August 2022). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health 23 (Suppl 1): S1–S259. PMID 36238954. PMC 9553112. DOI: 10.1080/26895269.2022.2100644.
(September 2018). Transgender medicine - puberty suppression. Reviews in Endocrine & Metabolic Disorders 19 (3): 221–225. PMID 30112593. DOI: 10.1007/s11154-018-9457-0.
(December 2014). Approach to the patient: transgender youth: endocrine considerations. The Journal of Clinical Endocrinology and Metabolism 99 (12): 4379–89. PMID 25140398. DOI: 10.1210/jc.2014-1919.
(April 2018). Hormonal Treatment in Young People With Gender Dysphoria: A Systematic Review. Pediatrics 141 (4): e20173742. PMID 29514975. DOI: 10.1542/peds.2017-3742.
(October 2017). Puberty suppression in transgender children and adolescents. The Lancet. Diabetes & Endocrinology 5 (10): 816–826. PMID 28546095. DOI: 10.1016/S2213-8587(17)30099-2.
(May 2017). Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents. The Journal of Sexual Medicine 14 (5): 747–757. PMID 28499525. DOI: 10.1016/j.jsxm.2017.03.251.

nos.nl

Diane 35-pil niet uit de handel NOS, 1 maart 2013
'Mogelijk 10 doden door Diane-35' NOS, 2 maart 2013

ucsf.edu

transhealth.ucsf.edu

(17 June 2016). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People (Center of Excellence for Transgender Health: University of California, San Francisco).

web.archive.org

Registratiekst Nederland Diane 35, samenvatting van de productkenmerken CBG, 3 april 2012